Kurzübersicht für PRAMEF2 Antikörper (C-Term) (ABIN5538775)
Target
PRAMEF2
(PRAME Family Member 2 (PRAMEF2))
Reaktivität
Human
Wirt
Kaninchen
Klonalität
Polyklonal
Konjugat
Dieser PRAMEF2 Antikörper ist unkonjugiert
Applikation
Western Blotting (WB)
Bindungsspezifität
AA 388-417, C-Term
Aufreinigung
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This PRAMEF2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 388-417 amino acids from the C-terminal region of human PRAMEF2.
PRAMEF2
Reaktivität: Human
WB, EIA
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.